Esa R Korpi Selected Research

Esa R Korpi Research Topics

Disease

5	Alcoholism (Alcohol Abuse) 07/2017 - 04/2004
4	Anxiety Disorders (Anxiety Disorder) 01/2014 - 04/2004
3	Schizophrenia (Dementia Praecox) 01/2019 - 01/2011
3	Substance-Related Disorders (Drug Abuse) 02/2014 - 03/2003
2	Pain (Aches) 06/2019 - 05/2006
2	Mania (Manias) 01/2019 - 01/2011
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2018 - 04/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014 - 09/2005
2	Mental Disorders (Mental Disorder) 01/2011 - 01/2007
2	Epilepsy (Aura) 03/2010 - 01/2006
1	Periodontitis 01/2023
1	Gambling (Pathological Gambling) 01/2020
1	Inflammation (Inflammations) 06/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019
1	Neuroblastoma 10/2015
1	Psychotic Disorders (Schizoaffective Disorder) 12/2014
1	Myoclonus (Nocturnal Myoclonus) 01/2014
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2014
1	Mood Disorders (Mood Disorder) 01/2014
1	Ataxia (Dyssynergia) 01/2014
1	Seizures (Absence Seizure) 01/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2014
1	Melanoma (Melanoma, Malignant) 02/2011
1	Cerebral Hemorrhage 10/2009
1	Brain Infarction 10/2009
1	Wounds and Injuries (Trauma) 09/2005
1	Spinal Cord Injuries (Spinal Cord Injury) 09/2005
1	Amnesia (Dissociative Amnesia) 07/2005
1	Temporal Lobe Epilepsy 09/2003
1	Dyskinesias (Dyskinesia) 03/2003

Drug/Important Bio-Agent (IBA)

5	gamma-Aminobutyric Acid (GABA)IBA 01/2011 - 09/2003
3	Glutamic Acid (Glutamate)FDA Link 01/2014 - 09/2005
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2020 - 03/2003
2	AMPA Receptors (AMPA Receptor)IBA 01/2019 - 01/2011
2	GABA-A Receptors (GABA(A) Receptor)IBA 01/2014 - 09/2003
2	Messenger RNA (mRNA)IBA 01/2011 - 09/2003
2	Neurotransmitter Agents (Neurotransmitter)IBA 03/2010 - 01/2006
2	BenzodiazepinesIBA 04/2009 - 04/2004
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2023
1	Lysergic Acid Diethylamide (LSD)IBA 01/2020
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2020
1	Hallucinogens (Psychedelics)IBA 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2019
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Pregabalin (Lyrica)FDA Link 01/2018
1	Naloxone (Narcan)FDA LinkGeneric 01/2018
1	Morphine (MS Contin)FDA LinkGeneric 01/2018
1	nalmefene (Revex)FDA Link 07/2017
1	Narcotic Antagonists (Opioid Antagonists)IBA 07/2017
1	Naltrexone (ReVia)FDA LinkGeneric 07/2017
1	Amphetamine (Amfetamine)FDA LinkGeneric 10/2015
1	mephedroneIBA 10/2015
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 12/2014
1	Glutamate Receptors (Glutamate Receptor)IBA 12/2014
1	NeurosteroidsIBA 02/2014
1	RNA (Ribonucleic Acid)IBA 01/2014
1	Cystatin BIBA 01/2014
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2014
1	gaboxadol (THIP)IBA 04/2012
1	CholesterolIBA 02/2011
1	Adenosine Triphosphatases (ATPase)IBA 02/2011
1	Caveolin 1IBA 02/2011
1	AcidsIBA 01/2011
1	Hypnotics and Sedatives (Sedatives)IBA 04/2009
1	Flumazenil (Romazicon)FDA LinkGeneric 04/2009
1	Flurazepam (Dalmane)FDA LinkGeneric 04/2009
1	Proteins (Proteins, Gene)FDA Link 01/2007
1	CannabinoidsIBA 05/2006
1	Kainic Acid (Kainate)IBA 09/2005
1	lysyl aspartic acidIBA 09/2005
1	Anesthetics (Anesthetic Agents)IBA 07/2005
1	Anti-Anxiety Agents (Anxiolytics)IBA 04/2004
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2003
1	Dopamine (Intropin)FDA LinkGeneric 03/2003
1	Dopamine Agents (Dopaminergic Agents)IBA 03/2003

Therapy/Procedure

3	Anesthesia 01/2014 - 01/2006
2	Self Administration (Administration, Self) 01/2018 - 04/2012
1	Decompressive Craniectomy 10/2009
1	Drug Therapy (Chemotherapy) 04/2009